BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8553449)

  • 1. Reversal of amenorrhoea after Mectizan treatment.
    Anosike JC; Abanobi OC
    Trop Geogr Med; 1995; 47(5):222-4. PubMed ID: 8553449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The varied beneficial effects of ivermectin (Mectizan) treatment, as observed within onchocerciasis foci in south-eastern Nigeria.
    Anosike JC; Dozie IN; Ameh GI; Ukaga CN; Nwoke BE; Nzechukwu CT; Udujih OS; Nwosu DC
    Ann Trop Med Parasitol; 2007 Oct; 101(7):593-600. PubMed ID: 17877878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multi-centre study of the effect of Mectizan treatment on onchocercal skin disease: clinical findings.
    Ogbuagu KF; Eneanya CI
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S139-45. PubMed ID: 9861280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The African Programme for Onchocerciasis Control: impact on onchocercal skin disease.
    Ozoh GA; Murdoch ME; Bissek AC; Hagan M; Ogbuagu K; Shamad M; Braide EI; Boussinesq M; Noma MM; Murdoch IE; Sékétéli A; Amazigo UV
    Trop Med Int Health; 2011 Jul; 16(7):875-83. PubMed ID: 21481109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resumption of menstruation in three women with secondary amenorrhoea after treatment with ivermectin.
    Anosike JC; Abanobi OC
    Ann Trop Med Parasitol; 1995 Dec; 89(6):693-4. PubMed ID: 8745946
    [No Abstract]   [Full Text] [Related]  

  • 6. A longitudinal study of impact of repeated mass ivermectin treatment on clinical manifestations of onchocerciasis in Imo State, Nigeria.
    Emukah EC; Osuoha E; Miri ES; Onyenama J; Amazigo U; Obijuru C; Osuji N; Ekeanyanwu J; Amadiegwu S; Korve K; Richards FO
    Am J Trop Med Hyg; 2004 May; 70(5):556-61. PubMed ID: 15155991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Onchodermatitis (sowda) in patients in Yémen. Clinical and histologic course after treatment with ivermectin].
    al Qubati Y; Reynouard F; Kumar F; Gaxotte P; Richard-Lenoble D
    Sante; 1997; 7(6):391-5. PubMed ID: 9503497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [10 years of mectizan donation].
    Boussinesq M; Godin C; Louis FJ
    Med Trop (Mars); 1997; 57(4):345-6. PubMed ID: 9612772
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduced prevalence of onchocerciasis following mass treatment with ivermectin.
    Oyibo WA; Fagbenro-Beyioku AF
    East Afr Med J; 1997 May; 74(5):326-30. PubMed ID: 9337014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mass treatment of onchocerciasis in 1996].
    Chovet M; Carlier C; Queguiner P; Mariko S
    Med Trop (Mars); 1995; 55(4 Pt 2):425-8. PubMed ID: 10906977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mectizan(®) procurement and delivery for onchocerciasis mass drug administration programmes.
    Ogoussan KT; Hopkins A
    Acta Trop; 2011 Sep; 120 Suppl 1():S173-6. PubMed ID: 20974105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contribution of mectizan to the control of onchocerciasis. Effect on transmission after 8 years of treatment].
    Boussinesq M
    Sante; 1998; 8(1):20-4. PubMed ID: 9592871
    [No Abstract]   [Full Text] [Related]  

  • 13. Control of onchocerciasis.
    Boatin BA; Richards FO
    Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The delivery of ivermectin (Mectizan).
    Burnham G; Mebrahtu T
    Trop Med Int Health; 2004 Apr; 9(4):A26-44. PubMed ID: 15078277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Operational lessons from 20 years of the Mectizan Donation Program for the control of onchocerciasis.
    Thylefors B; Alleman MM; Twum-Danso NA
    Trop Med Int Health; 2008 May; 13(5):689-96. PubMed ID: 18419585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contribution of mectizan to the control of onchocerciasis. Effect on transmission: evaluation of 9 years of treatment in West Africa].
    Hougard JM; Boatin B; Bissan Y; Akpoboua K; Sékétéli A
    Sante; 1998; 8(1):15-9. PubMed ID: 9592870
    [No Abstract]   [Full Text] [Related]  

  • 17. After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues.
    Katabarwa M; Eyamba A; Habomugisha P; Lakwo T; Ekobo S; Kamgno J; Kuete T; Ndyomugyenyi R; Onapa A; Salifou M; Ntep M; Richards FO
    Trop Med Int Health; 2008 Sep; 13(9):1196-203. PubMed ID: 18631308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of ivermectin treatment alone and when in parallel with Simulium neavei elimination on onchocerciasis in Uganda.
    Ndyomugyenyi R; Tukesiga E; Büttner DW; Garms R
    Trop Med Int Health; 2004 Aug; 9(8):882-6. PubMed ID: 15303993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Onchocerciasis and the Mectizan donation program].
    Gaxotte P
    Sante; 1998; 8(1):9-11. PubMed ID: 9592868
    [No Abstract]   [Full Text] [Related]  

  • 20. [Onchocerciasis control program in Chad: the Mectizan donation].
    Namangué K
    Sante; 1998; 8(1):51-2. PubMed ID: 9592880
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.